-Lariox Pharma Delivers Lifeline: Successful Early Access Program February 2024

marked a significant humanitarian victory for Lariox Pharma as our dedicated team successfully facilitated the delivery of an unlicensed, life-saving drug to a patient in critical need through our Early Access Program (EAP).

Overcoming numerous hurdles associated with securing approvals for unlicensed controlled medications, our team demonstrated exceptional perseverance and expertise. This achievement was made possible through our esteemed collaboration with a global leader in EAP access, who placed their trust in Lariox Pharma's capabilities.

We are immensely proud of our team's commitment to patient welfare and our ability to make a tangible difference in the lives of those in need. This success underscores Lariox Pharma's dedication to providing innovative solutions and expanding access to vital medications.